These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine. Badger AM; Cook MN; Swift BA; Newman-Tarr TM; Gowen M; Lark M J Pharmacol Exp Ther; 1999 Aug; 290(2):587-93. PubMed ID: 10411566 [TBL] [Abstract][Full Text] [Related]
28. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. Hoffman RA; Langrehr JM; Billiar TR; Curran RD; Simmons RL J Immunol; 1990 Oct; 145(7):2220-6. PubMed ID: 2144548 [TBL] [Abstract][Full Text] [Related]
29. Nitric oxide inhibition of IGF-1 stimulated proteoglycan synthesis: role of cGMP. Studer RK; Decker K; Melhem S; Georgescu H J Orthop Res; 2003 Sep; 21(5):914-21. PubMed ID: 12919881 [TBL] [Abstract][Full Text] [Related]
30. T-cell mitogenic responses in fully xenogeneic chimeras (WF rat----B10 mouse) are restored by blocking the L-arginine-dependent nitric oxide pathway. Wren SM; Hoffman RA; Billiar TR; Abou el Ezz A; Hronakes ML; Ildstad ST Transplant Proc; 1992 Apr; 24(2):499-500. PubMed ID: 1566404 [No Abstract] [Full Text] [Related]
31. Nitric oxide-induced anti-mitogenic effects in high and low responder rat strains. Fu Y; Blankenhorn EP J Immunol; 1992 Apr; 148(7):2217-22. PubMed ID: 1545127 [TBL] [Abstract][Full Text] [Related]
32. Arginine analogues suppress antigen-specific and -nonspecific T lymphocyte proliferation. Gregory SH; Sagnimeni AJ; Wing EJ Cell Immunol; 1994 Feb; 153(2):527-32. PubMed ID: 8118880 [TBL] [Abstract][Full Text] [Related]
33. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities. Cipolletta C; Jouzeau JY; Gegout-Pottie P; Presle N; Bordji K; Netter P; Terlain B Br J Pharmacol; 1998 Aug; 124(8):1719-27. PubMed ID: 9756389 [TBL] [Abstract][Full Text] [Related]
34. Cytostasis is required for IL-1 induced nitric oxide production in transformed hamster fibroblasts. Lavnikova N; Lakhotia A; Patel N; Prokhorova S; Laskin DL J Cell Physiol; 1996 Dec; 169(3):532-7. PubMed ID: 8952702 [TBL] [Abstract][Full Text] [Related]
35. Nitric oxide modulates lymphocyte proliferation but not secretion of IL-2. Huot AE; Moore AL; Roberts JD; Hacker MP Immunol Invest; 1993 Jun; 22(4):319-27. PubMed ID: 7689536 [TBL] [Abstract][Full Text] [Related]
36. Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases. Häuselmann HJ; Stefanovic-Racic M; Michel BA; Evans CH J Immunol; 1998 Feb; 160(3):1444-8. PubMed ID: 9570565 [TBL] [Abstract][Full Text] [Related]
37. Nitric oxide (NO) and cartilage metabolism: NO effects are modulated by superoxide in response to IL-1. Jouzeau JY; Pacquelet S; Boileau C; Nedelec E; Presle N; Netter P; Terlain B Biorheology; 2002; 39(1-2):201-14. PubMed ID: 12082283 [TBL] [Abstract][Full Text] [Related]
38. Nitric oxide and G proteins mediate the response of bovine articular chondrocytes to fluid-induced shear. Das P; Schurman DJ; Smith RL J Orthop Res; 1997 Jan; 15(1):87-93. PubMed ID: 9066531 [TBL] [Abstract][Full Text] [Related]
39. Nitric oxide produced by macrophages mediates suppression of ConA-induced proliferative responses of splenic leukocytes in the diabetes-prone BB rat. Lee KU Diabetes; 1994 Oct; 43(10):1218-20. PubMed ID: 7926291 [TBL] [Abstract][Full Text] [Related]
40. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture. Häuselmann HJ; Oppliger L; Michel BA; Stefanovic-Racic M; Evans CH FEBS Lett; 1994 Oct; 352(3):361-4. PubMed ID: 7926002 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]